In an editorial, Brendon Neuen, MBBS, PhD (George Institute for Global Health/University of New South Wales, Sydney, Australia), and Scott Solomon, MD (Brigham and Womens Hospital, Boston, MA), write that one of the most pressing questions is not which drug class is most effective, but rather who would benefit most from both SGLT2 inhibitors and GLP-1 receptor agonists
Tolerability only
In medical terminology, this is called gastric emptying. Patients who have food in their stomach while undergoing general anesthesia or deep sedation for surgery are at increased risk for a potentially serious complication
Diabetes drugs like Ozempic can often cause users to lose weight, but this particular medication has not been approved as a safe weight-loss treatment
Human studies indicate that the insulinotropic action of GIP is blunted in individuals with severe hyperglycemia, in contrast to the intact action of GLP-1